Quantum Technology Partners invests in early stage technology and life sciences companies., Inc., headquartered in New York, NY is a privately held clinical stage biopharmaceutical company that is developing next-generation botulinum-based prescription products for medical dermatology and aesthetic medicine. Anterios has developed the proprietary NDSTM platform technology that enables local, targeted delivery of botulinum toxin and other macromolecules across the skin without needles or other invasive treatments that can be destructive to the skin. Co-investors include Ascent Biomedical Ventures and Scientific Health Development, Ltd. Sciences, Inc., headquartered in South San Francisco, CA, was acquired by Sanofi. (NYSE:SNY). BiPar was in the development and commercialization of novel therapies to treat cancers for which current therapies are inadequate and/or are commonly associated with debilitating side effects.  The Company's initial focus is the  development and commercialization of three pre clinical, small molecule drug candidates for the treatment of breast and ovarian cancers. Co-investors include Domain Associates, Vulcan Capital, Canaan Partners and Asset Management Company. International, Inc., (NASDAQ: CORI) headquartered in Menlo Park, CA is engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. Essex Woodlands was the lead co-investor. Ltd., located in Ramat Gan, Israel is a biopharmaceutical company that is committed to, and engaged in the development of a new drug for enhancement of male fertility. The company has discovered a unique enzyme that can significantly enhance the fertility of sub-fertile males, based on technology that was developed by Professor Benjamin Bartoov from the Faculty of Life Sciences at Bar-Ilan University., Inc., based in San Francisco, is leading the reinvention of the smoking experience with its premium loose leaf and pod-system vaporizers. Ploom creates superior, beautiful and technologically advanced products that redefine the future of the tobacco industry. Co-investors include Japan Tobacco International and Tao Capital. Systems, Inc. is a private health-tech company that pioneers smart solutions for the safe manufacture, preparation, delivery, and disposal of intravenous and other liquid medications. The Company is developing medical devices to catch life-threatening IV drug errors before they harm patients. Lasers Plc  (formerly Southampton Photonics), based in Southampton, U.K. was acquired by TRUMPF GmbH + Co. SPI  is a leader in high power fiber lasers in the industrial, aerospace, analytical, sensing and communications markets. Co-investors include Advent Venture Partners, Amadeus Capital Partners, InterWest Partners and Sevin Rosen. Vaxart, Inc., located in San Francisco, California, is a biotechnology company developing oral vaccinations against infectious diseases. Vaxart's proprietary technology permits rapid, low cost, high volume production of orally delivered vaccines for a wide range of infectious agents. Quantum co-led the Series A financing with Life Science Angels. Bay Partners also participated in the financing.


[ Home ] [ Introduction ] [ Portfolio ] [ For Investors ] [ For Entrepreneurs ] [ Contact Us ]

copyright 2005, Quantum Technology Partners
site design by Growth Communications